Načítá se...
HTiP: High-throughput immunomodulator phenotypic screening platform to reveal IAP antagonists as anti-cancer immune enhancers
Protein- and cell-based immunotherapeutic agents have revolutionized cancer treatment. However, small molecule immunomodulators with favorable pharmacological properties to reach intracellular targets remain to be developed. To explore the vast chemical space, a robust method that recapitulates the...
Uloženo v:
| Vydáno v: | Cell Chem Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501824/ https://ncbi.nlm.nih.gov/pubmed/30639259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2018.11.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|